Prognostic utility of right ventricular systolic functions assessed by tissue doppler imaging in dilated cardiomyopathy and its correlation with plasma nt-pro-bnp levels

Congestive Heart Failure

Volumn 15, Issue 5, 2009, Pages 234-239

  Tigen, Kursat ^a   Karaahmet, Tansu ^a   Cevik, Cihan ^b   Gurel, Emre ^a   Pala, Selcuk ^a   Mutlu, Bulent ^a   Basaran, Yelda ^a  

^a KOSUYOLU HEART AND RESEARCH HOSPITAL   (Turkey)

^b TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BRAIN NATRIURETIC PEPTIDE; PEPTIDE FRAGMENT; PRO-BRAIN NATRIURETIC PEPTIDE (1-76);

ADULT; ARTICLE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; HEART CONTRACTION; HEART RIGHT VENTRICLE FUNCTION; HEART RIGHT VENTRICLE SYSTOLIC FUNCTION; HEART VENTRICLE SEPTUM; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; SENSITIVITY AND SPECIFICITY; TISSUE DOPPLER IMAGING; TRICUSPID VALVE; BLOOD; DOPPLER FLOWMETRY; ECHOGRAPHY; HEART LEFT VENTRICLE FUNCTION; HEART STROKE VOLUME; HEART VENTRICLE; KAPLAN MEIER METHOD; MIDDLE AGED; PATHOLOGY; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT; STATISTICS; SYSTOLE;

ADULT; CARDIOMYOPATHY, DILATED; FEMALE; HEART VENTRICLES; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PROGNOSIS; PROSPECTIVE STUDIES; RISK ASSESSMENT; ROC CURVE; SENSITIVITY AND SPECIFICITY; STATISTICS AS TOPIC; STROKE VOLUME; SYSTOLE; ULTRASONOGRAPHY, DOPPLER; VENTRICULAR FUNCTION, LEFT;

EID: 70349759759     PISSN: 15275299     EISSN: 17517133     Source Type: Journal    
DOI: 10.1111/j.1751-7133.2009.00095.x     Document Type: Article

References (29)

1. Shah MR, Hasselblad V, Gheorghiade M. Prognostic usefulness of the six-minute walk in patients with advanced congestive heart failure secondary to ischemic or nonischemic cardiomyopathy. Am J Cardiol 2001, 88:987-993.
2. Morley D, Brozena SC. Assessing risk by hemodynamic profile in patients awaiting cardiac transplantation. Am J Cardiol 1994, 73:379-383.
3. Aaronson KD, Schwartz JS, Chen TM. Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation. Circulation 1997, 95:2660-2667.
4. Meluzin J, Spinarová L, Hude P. Combined right ventricular systolic and diastolic dysfunction represents a strong determinant of poor prognosis in patients with symptomatic heart failure. Int J Cardiol 2005, 105:164-173.
5. Meluzín J, Spinarová L, Dusek L. Prognostic importance of the right ventricular function assessed by Doppler tissue imaging. Eur J Echocardiogr 2003, 4:262-271.
6. Meluzin J, Spinarová L, Hude P. Prognostic importance of various echocardiographic right ventricular functional parameters in patients with symptomatic heart failure. J Am Soc Echocardiogr 2005, 18:435-444.
7. Yvorchuk KJ, Davies RA, Chan KL. Measurement of left ventricular ejection fraction by acoustic quantification and comparison with radionuclide angiography. Am J Cardiol 1994, 74:1052-1056.
8. Recusani F, Bargiggia GS, Yoganathan AP. A new method for quantification of regurgitant flow rate using color Doppler flow imaging of the flow convergence region proximal to a discrete orifice. An in vitro study. Circulation 1991, 83:594-604.
9. Shiota T, Jones M, Teien DE. Evaluation of mitral regurgitation using a digitally determined color Doppler flow convergence " centerline" acceleration method. Studies in an animal model with quantified mitral regurgitation. Circulation 1994, 89:2879-2887.
10. Di Salvo TG, Mathier M, Semigran MJ. Preserved right ventricular ejection fraction predicts exercise capacity and survival in advanced heart failure. J Am Coll Cardiol 1995, 25:1143-1153.
11. Ghio S, Gavazzi A, Campana C. Independent and additive prognostic value of right ventricular systolic function and pulmonary artery pressure in patients with chronic heart failure. J Am Coll Cardiol 2001, 37:183-188.
12. Gavazzi A, Berzuini C, Campana C. Value of right ventricular ejection fraction in predicting short-term prognosis of patients with severe chronic heart failure. J Heart Lung Transplant 1997, 16:774-785.
13. de Groote P, Millaire A, Foucher-Hossein C. Right ventricular ejection fraction is an independent predictor of survival in patients with moderate heart failure. J Am Coll Cardiol 1998, 32:948-954.
14. Polak JF, Holman BL, Wynne J. Right ventricular ejection fraction: an indicator of increased mortality in patients with congestive heart failure associated with coronary artery disease. J Am Coll Cardiol 1983, 2:217-224.
15. Juilliere Y, Barbier G, Feldmann L. Additional predictive value of both left and right ventricular ejection fractions on long-term survival in idiopathic dilated cardiomyopathy. Eur Heart J 1997, 18:276-280.
16. Karatasakis GT, Karagounis LA, Kalyvas PA. Prognostic significance of echocardiographically estimated right ventricular shortening in advanced heart failure. Am J Cardiol 1998, 82:329-334.
17. Ghio S, Recusani F, Klersy C. Prognostic usefulness of the tricuspid annular plane systolic excursion in patients with congestive heart failure secondary to idiopathic or ischemic dilated cardiomyopathy. Am J Cardiol 2000, 85:837-842.
18. Meluzín J, Spinarová L, Bakala J. Pulsed Doppler tissue imaging of the velocity of tricuspid annular systolic motion. A new, rapid and non-invasive method of evaluating right ventricular systolic function. Eur Heart J 2001, 22:340-348.
19. La Vecchia L, Paccanaro M, Bonanno C. Left ventricular versus biventricular dysfunction in idiopathic dilated cardiomyopathy. Am J Cardiol 1999, 83:120-122. A9
20. La Vecchia L, Zanolla L, Varotto L. Reduced right ventricular ejection fraction as a marker for idiopathic dilated cardiomyopathy compared with ischemic left ventricular dysfunction. Am Heart J 2001, 142:181-189.
21. Iskandrian AS, Helfeld H, Lemlek J. Differentiation between primary dilated cardiomyopathy and ischemic cardiomyopathy based on right ventricular performance. Am Heart J 1992, 123:768-773.
22. Brieke A, DeNofrio D. Right ventricular dysfunction in chronic dilated cardiomyopathy and heart failure. Coron Artery Dis 2005, 16:5-11.
23. Chandra R. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation 2005, 112:e154-e235.
24. Troughton RW, Frampton CM, Yandle TG. Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations. Lancet 2000, 355:1126-1130.
25. Maisel AS, Krishnaswamy P, Nowak RM. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 2002, 347:161-167.
26. Troughton RW, Prior DL, Pereira JJ. Plasma B-type natriuretic peptide levels in systolic heart failure: importance of left ventricular diastolic function and right ventricular systolic function. J Am Coll Cardiol 2004, 43:416-422.
27. Tulevski II, Groenink M, van Der Wall EE. Increased brain and atrial natriuretic peptides in patients with chronic right ventricular pressure overload: correlation between plasma neurohormones and right ventricular dysfunction. Heart 2001, 86:27-30.
28. Matsuo K, Nishikimi T, Yutani C. Diagnostic value of plasma levels of brain natriuretic peptide in arrhythmogenic right ventricular dysplasia. Circulation 1998, 98:2433-2440.
29. Vogelsang TW, Jensen RJ, Monrad AL. Independent effects of both right and left ventricular function on plasma brain natriuretic peptide. Eur J Heart Fail 2007, 9:892-896.